Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Nanosphere Assay for Coagulation-Linked Gene Mutations

NEW YORK (GenomeWeb News) — Nanosphere today said that the US Food and Drug Administration has cleared a test that detects gene mutations linked with blood coagulation and metabolism disorders.
 
Nanosphere’s F5/F2/MTHFR Nucleic Acid Test runs on the company’s Verigene System and can be applied in single or multiplex formats.
 
It tests for mutations in three specific genes that together can increase the risk of blood clots and resulting ischemic stroke.
 
As GenomeWeb Daily News reported, the FDA last month cleared Nanosphere’s test for gene variants linked to sensitivity to the anticoagulant warfarin.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.